Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells

CD19-directed CAR-T-cells (CD19-CAR) have demonstrated remarkable clinical results in patients suffering from refractory or relapsed lymphoma and acute lymphoblastic leukemia. In order to further optimize follow-up, to explain treatment failure, and to control adverse events biomarkers for monitorin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mika, Thomas, Maghnouj, Abdelouahid, Klein-Scory, Susanne, Ladigan-Badura, Swetlana, Baraniskin, Alexander, Thomson, Julia, Hasenkamp, Justin, Hahn, Stephan A., Wulf, Gerald, Schroers, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243121/
https://www.ncbi.nlm.nih.gov/pubmed/32500079
http://dx.doi.org/10.3389/fmolb.2020.00084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243121/
https://www.ncbi.nlm.nih.gov/pubmed/32500079
http://dx.doi.org/10.3389/fmolb.2020.00084

Ejemplares similares